好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Sexual Dysfunction and Autonomic Symptoms in Women with Hypermobility Spectrum Disorders: A Cross-Sectional, Community-Based Study
Neuromuscular and Clinical Neurophysiology (EMG)
P3 - Poster Session 3 (11:45 AM-12:45 PM)
7-003

We sought to assess autonomic symptom burden and sexual function in women with HSD/h-EDS and compare their autonomic symptom and sexual dysfunction severity to women with POTS.

Hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (h-EDS) are connective tissue disorders associated with joint hypermobility, pain, fatigue and autonomic dysfunction.

This was an IRB-approved cross-sectional community-based study where participants completed the following online questionnaires: (1) COMPASS-31; (2) Female sexual function index (FSFI); (3) Beck Depression Inventory and (4) one additional short form with questions pertaining to comorbidities and sexual activity.

84 female HSD/EDS patients, mean age of 37.1±8.4, participated. 58% reported a concurrent diagnosis of POTS and 25% reported having a triad of POTS, HSD/h-EDS and MCAS. Mean COMPASS-31 score was 51.5±13.8; mean depression score was 24.6 ±11.4, and mean FSFI score was 15.3±7.9. Only 19 (22.6%) women reported having sexual intercourse with a partner in the past 4 weeks, and additional 2 (2.4%) women reported having sexual intercourse with a partner in the past 3 months. Lowest FSFI scores were in the domains of pain (2.1±1.9) and desire (2.2±0.9) followed by arousal (2.6±1.8), lubrication (2.6±2.1), satisfaction (2.8±1.4), and orgasm (2.8±1.9). Compared to patients with POTS, patients with HSD/h-EDS reported greater sexual dysfunction overall and across all domains measured in the FSFI (pain with intercourse, satisfaction, orgasm, arousal, desire, and lubrication).

Women with HSD/h-EDS experience significant autonomic symptom burden and sexual dysfunction, which is greater than in women with POTS. Given its implications in reproduction, relationships, family planning and overall health and well- being, sexual dysfunction represents a significant unmet need that calls for development of targeted diagnostic and therapeutic approaches in the care of patients with HSD/h- EDS.

Authors/Disclosures
Emily Fuster
PRESENTER
Miss Fuster has nothing to disclose.
Svetlana Blitshteyn, MD, FAAN (Dysautonomia Clinic) Dr. Blitshteyn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Blitshteyn has received publishing royalties from a publication relating to health care. Dr. Blitshteyn has received personal compensation in the range of $500-$4,999 for serving as a Healthcare Expert with Agency for Healthcare Quality and Research, US Health and Human Services.